Clinico-radiological profile of arrhythmogenic right ventricular dysplasia at a tertiary care center: Two year experience  by Shaheen, Feroze et al.
P.O. Box 2925 Riyadh – 11461KSA
Tel: +966 1 2520088 ext 40151













Received 22 January 2013; revised 6 March 2013; accepted 7 March 2013.
Available online 21 March 2013
⇑ Corresponding author.
E-mail addresses: shaheengp64@rediffmail.com (F. Shaheen), Iqbal.
khurshid@gmail.com (K. Iqbal), imihaf@gmail.com (I. Hafeez),
naseerchoh@rediffmail.com (Naseer.A. Choh), drnisartramboo@gmail.
com (N.A Tramboo), drajaz66@yahoo.com (A. Lone), drshamimiqbal@
gmail.com (S. Iqbal), wasim.skims@gmail.com (W. Ahmed),
amitcardio12@gmail.com (A. Gupta).Clinico-radiological profile of arrhythmogenic right
ventricular dysplasia at a tertiary care center: Two
year experienceFeroze Shaheen a, Khurshid Iqbal b, Imran Hafeez b,⇑, Naseer.A. Choh a,
Nisar A Tramboo b, Ajaz Lone b, Shamim Iqbal b, Wasim Ahmed b, Amit Gupta ba Department of Radiology, Shere-Kashmir-Institute of Medical Sciences (SKIMS), Soura, Srinagar, J&K 190 011
b Department of Cardiology, Shere-Kashmir-Institute of Medical Sciences (SKIMS), Soura, Srinagar, J&K 190 011
a–bIndiaBackground: Arrythmogenic right ventricular dysplasia (ARVD/C) refers to fibro fatty infiltration replacement of
ventricular myocardium especially that of right ventricle. The clinical presentation varies from asymptomatic state to
ventricular tachycardia, heart failure and even sudden death. Diagnosis is established using modified ARVD/C
taskforce criteria. Among all the various modalities of diagnosis, magnetic resonance imaging (MRI) gives most
comprehensive evaluation of both morphological and functional abnormalities in this disease. MRI may not only
obviate need for myocardial biopsy but also give insights into the nature of disease like presence of left ventricular
myocardial involvement. We present our 2 years experience of ARVD/C patents who were admitted in our center and in
whom diagnosis of ARVD/C was supported by excellent MR imaging.
Materials and methods: This study was conducted by Department of Radiology and Cardiology SKIMS, a tertiary
care center for a period of 2 years. Patients with suspected ARVD/C based on clinical, electrophysiological and echo-
cardiographic findings were subjected to MR imaging. Patients were excluded if they had history metallic implants,
claustrophobia or were uncooperative. In this study stress was laid on diagnostic role of MRI in ARVD/C.
Results: The median age at presentation was 31 years (range 21–43 years). 80% of patients were males. Most com-
mon clinical presentation was palpatations (40%). Syncope was present in 27% and heart failure in 13%. EKG sug-
gestive of ARVD was seen in 87%. Echocardiographic features suggestive of ARVD/C was seen in all 15 patients.
Family history of premature sudden death less than 35 years old was present in one patient only. MRI evidence clas-
sical for ARVD/C was seen in 80%.
Conclusion: Demographic features and mode of presentation of our patients is consistent with what has been rest
of the world. We performed MRI in all patients to increase the specificity of our diagnosis. MR imaging allows a
three-dimensional evaluation of the right ventricle and provides the most important anatomic, functional, and mor-
phologic criteria for diagnosis of ARVD/C within one single study. MR imaging appears to be the optimal imaging
technique for detection and follow-up of clinically suspected ARVD/C.
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Figure 1. A, B. T1W Double inversion recovery dark blood spin echo sequence showing fatty replacement of the right ventricular free wall and
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ARVD/C is a cardiomyopathy of unknown eti-ology characterized by structural and func-
tional abnormalities of right ventricle leading to
ventricular arrhythmias and progressive right
heart failure. It presents in sporadic and familial
forms and has an overall prevalence of 1:5000 in
USA. Annual death rate from ARVD/C is esti-
mated to be 2.5% [1]. The disease is recognized
as a major cause of death in young adolescents
and in one series it accounted for 20% of sudden
death in all individuals younger than 35 years
and 22% deaths in young athletes [2]. Underlying
pathological substrate of ARVD/C is myocyte loss
with fibro fatty replacement of ventricular myo-
cardium, focal thinning of right ventricular myo-
cardium resulting in global or regional
contraction abnormalities. Defective desmosomal
proteins are the presumed cause of majority of
familial cases of ARVD/C but not proven for spo-
radic cases without genetic origin. Although most
cases of familial origin are autosomal dominant
with mutations affecting components of cardiac
desmosomal proteins resulting in disruption of
cell to cell adhesions and myocyte loss, the clinical
manifestations are variable ranging from com-
plete lack of symptoms to severe disease. This var-
iable expressivity of the disease may be due to
variable penetrance or other associated unknown
causes [3]. The diagnosis of ARVD/C is based on
the structural, histologic, electrocardiographic,
arrhythmic, and genetic factors proposed by
ARVD/C task force in 1994 [4]. Modified task force
criteria was proposed in 2010 [5]. The criteria have
been modified to incooperate new knowledge and
technology to improve diagnostic sensitivity butwith the important requisite of maintaining diag-
nostic specificity. Negative T waves in lead V1–
V3 and ARVD/C in first degree relative were
reclassified as major criteria; negative T waves in
V1–V2 or V4–V6, negative T waves in V1–V4 with
right bundle branch, terminal activation duration
(TAD) OF QRSP 55 ms in V1–V3, VT of left bun-
dle branch morphology with superior axis and
pathogenic mutation associated with ARVD/C
are newly introduced criteria; late potentials by
SAEG in at least one of the three parameters
and over >500 premature ventricular complexes/
24 h on holter are adaptations; quantification of
RV structural abnormalities and dysfunction and
tissue characterization by RV biopsy [6]. Magnetic
resonance imaging (MRI) allows multiplanar eval-
uation of the right ventricle (RV), enabling accu-
rate morphologic and functional assessment
without any geometric assumptions [7]. Intramyo-
cardial fat accumulation is a pathologic hallmark
of ARVD/C, and MRI has excellent tissue charac-
terization capability, particularly for fatty tissue
[8–10]. The ability to provide tissue characteriza-
tion as well as to visualize RV function makes
MRI suitable for follow-up of patients and to study
the progression of disease (see Figs. 1 and 2).Materials and methods
This study was conducted by Department of
Radiology and Cardiology SKIMS, a tertiary care
center for a period of 2 years from 2009 to 2011. Pa-
tients with suspected ARVD/C based on clinical,
electrophysiological and echocardiographic find-
ings were subjected to MR imaging (Magnetom
Avanto, Siemens, Erlangen, Germany). Patients
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plants, claustrophobia or were uncooperative. In
this study stress was laid on diagnostic role of
MRI in ARVD/C. Following imaging techniques
were used:
TIW double inversion recovery black blood
sequence in axial, RVOT and short axis planes
followed by fat saturated T1W double inversion
recovery in same planes using same slice thick-
ness of 5 mm, slice gap 5 mm and FOV of 28 cm.
Thickness of 8 mm, slice gap 2 mm and field of
view (FOV) 36–40 cm using parallel imaging
technique.
Short axis steady state in free precession (SSFP)
cine for functional assessment.
Short axis, RVOT and LVOT planes for post
contrast LGE imaging with myocardial nulling
using slice thickness of 8 mm, slice gap 2 mm
with phase sensitive inversion recovery
sequence.
Right ventricular function analysis was done
using Argus analysis software (Siemens Medical
Solutions, Forchiem, Germany).
Dose of gadolinium used was 0.1 mmol/kg.Results
During the period of 2 years 15 patients with
suspected ARVD/C based on clinical, electrophys-iological and echocardiographic findings were
admitted in our institution. There demographic,
clinical and diagnostic parameters are depicted in
Table 1.
The median age at presentation was 31 years
(range 21–43 years). 80% of patients were males
(n = 12) and 20% were females (n = 2). Most com-
mon clinical presentation was palpatations (40%).
Syncope was present in 27% and heart failure in
13%. 20% of our patients were asymptomatic in
whom ARVD/C diagnosis was incidental finding.
EKG suggestive of ARVD as per modified ARVD
task force criteria (major or minor criteria) was
seen in 87% (n = 13). The most common electro-
cardiographic feature was T-wave inversion in
right precordial leads (80%) which is a major cri-
teria as per modified task force criteria. Episilon
wave was seen in one patient. Documented ven-
tricular tachycardia of LBBB morphology was
seen in 20% (n = 3). Echocardiographic features
suggestive of ARVD/C as per ARVD/C task force
criteria (major or minor criteria) were seen in all
15 patients. All patients had RV Dyskinesis with
RVOT dilatation which was important clue for
further diagnostic evaluation of ARVC/D. RV
aneurysms were seen in 26%. RVOT dimensions
in PSAX > 36 mm was seen in 80% and <36 in
20%. Family history of premature sudden death
less than 35 years old was present in one patient
only. Three patients received ICD, two patients















1 M 28 Syncope
2 M 36 Palpitations
3 M 33 Palpitations
4 M 41 Asymptomatic
5 F 21 Syncope
6 M 29 Palpitations
7 M 27 Asymptomatic
8 M 32 Syncope
9 F 39 Syncope
10 M 29 Palpitations
11 F 40 Heart failure
12 M 25 Palpitations
13 M 30 Asymptomatic
14 M 43 Heart failure
15 M 31 Palpitations
M, Male; F, Female.
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received it for primary prevention. Five of our
patients were admitted with recurrent heart fail-
ure during this period, four patients were lost
on follow up and rest are following us in reason-
ably good state.MRI finding in our patients
MRI evidence classical for ARVD/C was seen in
80% (n = 12). Following pattern was seen:
Three (20%) patients had fatty replacement of
right ventricular apex and sub tricuspid region
with normal right ventricular cavity with hypo-
kinesis of the involved ventricular wall. Clini-
cally all these patients had tachyarrhythmia
with epsilon waves in one patient.
Fibro fatty replacement of most of right ventric-
ular wall with post contrast enhancement,
dilated right ventricular cavity and reduced
right ventricular functions was seen in three
(20%) patients.
Markedly thinned right ventricular wall with
dilated right ventricular cavity, systolic a dia-
stolic dysfunction (evaluated by MR velocity
mapping across tricuspid valve) but no visible
hyperintense signal in right ventricular wall
on T1W sequence was see in four (26%)
patients.
Fibro fatty replacement of right ventricular wall
with epicardial enhancement of most of right
ventricular wall and IVS and part of left ventri-
cle with systolic dysfunction of right ventricle
with reduced ejection fraction was seen in two
(14%) patients.Discussion
ARVD/C results from fibro fatty replacement of
the right ventricular wall which in turn leads to
arrythmogenicity and progressive right ventricu-
lar failure unless punctuated by sudden death
due to arrhythmia. The cause of fatty or fibro fatty
replacement of ventricular wall has been postu-
lated on the basis of various genetic, pathologic,
clinical and biochemical findings. In a large pro-
portion of patients (30–80%) the disease is familial,
primarily autosomal dominant with variable pen-
etrance .Besides two autosomal recessive syn-
dromic forms of ARVD namely Naxos disease
and Carvajal syndrome have been discovered
having 100% genetic penetrance [1]. The dominant
form of disease shows polymorphic expressivity
ranging from complete lack of symptoms to severe
disease phenotype experiencing sudden death
which has been attributed to modifier genes, envi-
ronmental factors and gender effects [11]. The ge-
netic mutations involve mainly the desmosomal
proteins. The defective desmosomal proteins are
thought to result in disruption of cell to cell adhe-
sion causing myocyte detachment and apoptosis.
The walls most affected would be those which
are thinnest and have high mechanical stress like
the right ventricular wall [3]. Pathologically two
morphological variants are found; fatty and fibro
fatty. The former shows complete replacement of
myocardium without thinning of the wall and oc-
curs exclusively in right ventricle whereas the lat-
ter shows thinning of right ventricular wall and
part of left ventricular wall with fibro fatty
replacement. Classically the right ventricular wall
involvement occurs in what is known as triangle of
dysplasia i.e. right ventricular sub tricuspid area,
the apex and infundibulum [12].
The modified task force group on ARVD has
established various criteria for the diagnosis of
ARVD and divided them into major and minor cri-
teria with either two major or one major and two
minor criteria or four minor criteria being suffi-
cient for the diagnosis of ARVD [5]. Classically
the EKG shows regular sinus rhythm with
QRS > 110 ms in VI, Epsilon wave just beyond
QRS complex in VI and inversion of T waves in
precordal leads from V1 to V3 or ventricular
tachycardia of LBBB morphology [4]. 2D echocar-
diography reveals increase systolic and diastolic
dimensions, hyperrefractile moderator band and
apical aneurysms. Diastolic RVOT enlargement
is usually more common. An RVOT dimension
larger than 30 mm from PLAX view has highest
sensitivity (89%) and specificity (86%) for diagno-
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lacks sufficient sensitivity owing to segmental nat-
ure of disease. Even when biopsy is obtained from
right ventricular free wall, sensitivity is only 67%
based on the criteria of >3% fat and less than
40% fibrous tissue replacing myocardial muscle
[14]. Significant fatty replacement of the right ven-
tricle occurs in >50% of normal hearts in elderly
people and a degree of intramyocardial fat in the
anterior apex of right ventricle existed in 15% of
controls [15,16].
Magnetic resonance imaging has been used for
evaluation of ARVD/C for quite some time now
and has proved to be a robust and comprehensive
investigation tool.
The typical criteria that can be demonstrated
with MR imaging of ARVD/C are [17].
(A). Major:
1. Fatty infiltration of right ventricular myocar-
dium with high signal intensity on T1W.
2. Fibro fatty replacement leading to diffuse
thinning of right ventricular myocardium.
3. Aneurysm of right ventricle and right ven-
tricular outflow tract.
4. Severe dilatation of right ventricle and right
ventricular outflow tract.
5. Global systolic dysfunction.
(B). Minor:
1. Mild dilatation of right ventricle and right
ventricular outflow tract.
2. Regional contraction abnormalities.
3. Global diastolic dysfunction.
Our patients presented somewhere between
second decade to fifth decade, the youngest pa-
tient was 21 years old and oldest patient was
43 years old. This is consistent with the world lit-
erature [18,19]. In one of the largest cohort of
ARVD/C, patients typically presented between
the second and fifth decades of life. Although
only eight patients presented before the onset
of adolescence or after 50 years of age, the age
at presentation ranged widely between 2 and
70 years. The marked variability in age of presen-
tation suggests that ARVD remains concealed for
varying periods of time in different individuals
[19]. In our patients there was wide spectrum of
presentation from asymptomatic state to ventric-
ular tachycardia, syncope and heart failure which
is consistent with world literature. Palpatation
was most common symptom as seen in other
studies also [19]. In our patients EKG and echo-
cardiographic features supported diagnosis of
ARVD/C as per modified ARVD/C task force
criteria [5]. We performed MRI in all patients toincrease the specificity of our diagnosis and the
results of our MR imaging were consistent with
what has been seen in world literature. MRI
confirmed diagnosis of ARVD/C in majority of
our patients (80%).
MR imaging allows a three-dimensional evalua-
tion of especially the right ventricle and provides
the most important anatomic, functional, and
morphologic criteria for diagnosis of ARVD/C
within one single study. Although demonstration
of morphofunctional abnormalities of the right
ventricle, especially fat in the right ventricular
myocardium, shows high specificity but low sensi-
tivity, MR imaging appears to be the optimal
imaging technique for detection and follow-up of
clinically suspected ARVD/C [17]. Addition of fat
suppressed T1W sequences has significantly im-
proved interobserver agreement and allowed the
reviewers to be more confident in their interpreta-
tions. There is a reciprocal relationship between
sensitivity and specificity for non fat suppressed
and fat suppressed sequences with non fat sup-
pressed sequences showing better sensitivity
and fat suppressed sequences showing better
specificity [20].
Since the patients with ARVD/C usually have a
variable heart rate, fat signal will vary due to vary-
ing T1 weighting with increasing RR interval lead-
ing to decreased fat signal intensity. Thus factors
such as these may result in poor visualization of
fat despite being present. Evaluation of wall mo-
tion abnormalities in such cases is of immense
help in clinching the diagnosis [21]. The sensitivity
and specificity of MRI in diagnosis of ARVD/C is
96% and 78% respectively [22].Limitations of MRI
Unfamiliarity with normal right ventricular mor-
phology and function has led to high interob-
server and poor reproducibility in some series
[23]. The presence of in tramyocardial fat deposi-
tion in right ventricle must be interpreted with
caution, as fat in right ventricle is present in large
proportion of normal individuals (up to 85%) and
increases with age, body weight and female gen-
der [24].
We have used comprehensive protocol of T1W
non fat sat and T1W fat sat sequences in all our
patients along with True free induction in steady
state precession (FISP) steady state in free pre-
cession (SSFP) for morphology as well as func-
tion and post contrast late gadolinium
enhancement. We also used right ventricular
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2013;25:79–84In conclusion magnetic resonance imaging is a
robust and an accurate technique of evaluation
of morphological and functional abnormalities in
patients with ARVD/C l. The addition of fat sup-
pression sequences improves the interobserver
agreement in assessing fibro fatty infiltration of
right ventricular wall. Furthermore use of LGE
may reveal areas of fibro fatty infiltration hitherto
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